Unihealth Consultancy Ltd
Incorporated in 2010, Unihealth Consultancy Ltd is in the business of Medical Tour Operator and Health Consultancy Service & Trader in Medical Equipments[1]
- Market Cap ₹ 226 Cr.
- Current Price ₹ 147
- High / Low ₹ 178 / 109
- Stock P/E 61.7
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 8.91 %
- ROE 7.88 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Earnings include an other income of Rs.2.87 Cr.
- Company has high debtors of 225 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|
| 0.63 | 1.61 | 1.92 | 4.23 | 4.87 | |
| 0.74 | 0.79 | 1.36 | 2.28 | 2.42 | |
| Operating Profit | -0.11 | 0.82 | 0.56 | 1.95 | 2.45 |
| OPM % | -17.46% | 50.93% | 29.17% | 46.10% | 50.31% |
| -0.14 | 0.94 | 1.79 | 2.33 | 2.87 | |
| Interest | 0.80 | 1.19 | 1.15 | 0.34 | 0.02 |
| Depreciation | 0.11 | 0.09 | 0.08 | 0.16 | 0.25 |
| Profit before tax | -1.16 | 0.48 | 1.12 | 3.78 | 5.05 |
| Tax % | 0.00% | 0.00% | -19.64% | 19.84% | |
| -1.16 | 0.48 | 1.34 | 3.04 | 3.67 | |
| EPS in Rs | |||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 89% |
| TTM: | 120% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 67% |
| TTM: | 127% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 5% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|
| Equity Capital | 1.34 | 1.39 | 15.40 | 15.40 |
| Reserves | 5.17 | 11.28 | 49.07 | 50.20 |
| 11.60 | 12.08 | 3.30 | 1.15 | |
| 0.42 | 0.61 | 0.71 | 1.05 | |
| Total Liabilities | 18.53 | 25.36 | 68.48 | 67.80 |
| 1.50 | 1.42 | 3.09 | 3.21 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 6.15 | 6.34 | 18.37 | 23.05 |
| 10.88 | 17.60 | 47.02 | 41.54 | |
| Total Assets | 18.53 | 25.36 | 68.48 | 67.80 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| -0.84 | 1.97 | -2.46 | ||
| 0.73 | -7.17 | -10.50 | ||
| 0.15 | 5.09 | 39.57 | ||
| Net Cash Flow | 0.05 | -0.11 | 26.61 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Debtor Days | 476.09 | 117.86 | 225.21 | |
| Inventory Days | ||||
| Days Payable | ||||
| Cash Conversion Cycle | 476.09 | 117.86 | 225.21 | |
| Working Capital Days | 630.25 | 212.92 | 361.55 | |
| ROCE % | 10.59% | 8.91% |
Documents
Announcements
-
Name Change
21 November 2024 - The name of the Company Unihealth Consultancy Limited shall be changed to Unihealth Hospitals Limited w.e.f. November 27, 2024.
-
Analysts/Institutional Investor Meet/Con. Call Updates
21 November 2024 - Unihealth Consultancy Limited has informed about Schedule of meet
-
Analysts/Institutional Investor Meet/Con. Call Updates
15 November 2024 - Unihealth Consultancy Limited has informed about Transcript
-
Analysts/Institutional Investor Meet/Con. Call Updates
12 November 2024 - Unihealth Consultancy Limited has informed about Presentation
-
Analysts/Institutional Investor Meet/Con. Call Updates
12 November 2024 - Unihealth Consultancy Limited has informed about Link of Recording
Annual reports
Concalls
-
Nov 2024Transcript PPT
-
May 2024Transcript PPT
-
Nov 2023Transcript PPT
Business Overview:[1]
a) UHCL is an ISO 9001:2015 certified healthcare service provider with a global presence, especially in Africa.
b) The company operates medical centers and hospitals, provides consultancy services, distributes pharmaceutical and medical consumable products, and offers medical value travel.
c) UHCL is involved in healthcare consultancy projects in India and various African countries, and exports and distributes pharma and medical consumable products to Uganda, Tanzania, and Nigeria.
d) It acts as a distributor for several Indian manufacturers in these African nations.
e) The company has 4 centers and 2 hospitals, with over 150 doctors and specialists treating more than 1.10 lakh patients annually.
f) UHCL manages two multi-specialty facilities with a total of 200 operational beds and has over 1,200 beds in projects under consultancy.